Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
Schilling
M
M
Department of Surgery, LMU Munich, Klinikum Grosshadern, FRG.
Schleibner
S
S
Abendroth
D
D
Illner
W D
WD
Schneeberger
H
H
Land
W
W
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011239:Prednisolone / Q000627:therapeutic use*
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine